Search - tctmd.com

Displaying 21 - 40 of 73

Sort: Relevancy | Date

News Industry News

Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke

September 05, 2018

News Opinion Fellow Talk

Why I Chose a Career in Interventional Cardiology

Lowie Van Assche, MD

September 05, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Daily News

Aging Data: Study Highlights Delays From Time of Clinical Trial Enrollment to Publication

Yael L. Maxwell

August 15, 2018

Presentation CHIP Seattle 2018

How to Manage Your Attending/Partners as You Take on CHIP Cases

Presenter: Robert F. Riley

August 10, 2018

News Daily News

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

Shelley Wood

July 23, 2018

News Daily News

Medicare’s Bundled Payments Plan Hasn’t Cut Costs (Yet)

Caitlin E. Cox

July 18, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

News Daily News

Uphill Climb Seen for Implementation of US Blood Pressure Guidelines

Todd Neale

July 12, 2018

News Industry News

Venclose Completes Series B Financing and Announces the Appointment of Jeffrey G. Carr, MD as Chief Medical Officer and Gregory J. Vislocky to its Board of Directors

July 11, 2018

News Daily News

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

L.A. McKeown

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Partner 3 Low-Risk

Presenter: Martin B. Leon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Updates from the PARTNER Aortic Valve-in-Valve Registry

Presenter: Vinayak Bapat, Ran Kornowski, Michael J. Mack

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Presenter: Eberhard Grube, Tamim Nazif, Chetan P. Huded

June 21, 2018

News Industry News

Shifamed Announces $15.5M Series a Financing Supira Medical, Newly Formed Portfolio Company, Focuses on Next Generation PVAD

June 13, 2018

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Todd Neale

June 08, 2018

Presentation EuroPCR 2018

Real World Outcomes of TAVR with the SAPIEN-3 Valve in Intermediate Risk Patients: Comparison of Data from the TVT Registry with PARTNER S3 Studies

Presenter: E. Murat Tuzcu

May 25, 2018

News Conference News EuroPCR 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Caitlin E. Cox

May 25, 2018

News Daily News

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

Caitlin E. Cox

May 16, 2018

News Conference News SCAI 2018

Injured and Sleep Deprived: Are the Physical Tolls of Interventional Cardiology Too High?

L.A. McKeown

May 04, 2018

Advertisement

Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke

Why I Chose a Career in Interventional Cardiology

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Aging Data: Study Highlights Delays From Time of Clinical Trial Enrollment to Publication

How to Manage Your Attending/Partners as You Take on CHIP Cases

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

Medicare’s Bundled Payments Plan Hasn’t Cut Costs (Yet)

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Uphill Climb Seen for Implementation of US Blood Pressure Guidelines

Venclose Completes Series B Financing and Announces the Appointment of Jeffrey G. Carr, MD as Chief Medical Officer and Gregory J. Vislocky to its Board of Directors

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

Partner 3 Low-Risk

Updates from the PARTNER Aortic Valve-in-Valve Registry

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Shifamed Announces $15.5M Series a Financing Supira Medical, Newly Formed Portfolio Company, Focuses on Next Generation PVAD

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Real World Outcomes of TAVR with the SAPIEN-3 Valve in Intermediate Risk Patients: Comparison of Data from the TVT Registry with PARTNER S3 Studies

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

Injured and Sleep Deprived: Are the Physical Tolls of Interventional Cardiology Too High?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content